This page shows the latest Handl Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Handl Therapeutics – based in Leuven, Belgium – specialises in adeno-associated virus (AAV) capsid technology and has a focus on developing disease modifying gene therapies to treat neurodegenerative diseases. ... the development of gene therapies
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...